Sophiris halts cancer study after patient death
June 25, 2018Research and Development, Sales and Marketing Cancer, Sophiris, pharma, prostate cancer
Another clinical trial has been forced to a standstill as biotech firm Sophiris revealed that a patient death had prompted …
Eli Lilly’s dulaglutide doses show blood control and weight benefits at Phase 2
June 25, 2018Research and Development, Sales and Marketing Eli Lilly, Trulicity, diabetes, pharma
Eli Lilly has announced new data on its once-weekly, injectable glucagon-like peptide Trulicity (dulaglutide 1.5mg) and investigational 3.0 and 4.5mg …
J&J’s second-in-command to retire, alongside executive restructure
June 25, 2018Medical Communications, Sales and Marketing J&J, JJ, Johnson & Johnson, pharma
Johnson & Johnson’s Group Worldwide Chairman Sandra Peterson (pictured) has announced she is to retire from her role and the …
Roche’s Tecentriq combo extends life in untreated lung cancer
June 25, 2018Research and Development, Sales and Marketing Cancer, Roche, lung cancer, pharma, tecentriq
Roche has unveiled new data on the efficacy of Tecentriq (atezolizumab) in combination with chemotherapy (carboplatin and etoposide) for the …
Top Ten most popular articles on Pharmafile.com this week
June 22, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharma, top ten
The sun is out in the UK, it’s Friday, and the July/August issue of Pharmafocus is going to print. And, …
NICE backs Sanofi’s new treatment for atopic dermatitis
June 22, 2018Medical Communications, Sales and Marketing England, NICE, Sanofi, UK, atopic dermatitis, pharma
NICE has published a positive Final Appraisal Determination FAD recommending dupilumab, in combination with topical corticosteroids, for use on the …
FDA approves first continuous glucose monitoring system
June 22, 2018Medical Communications, Sales and Marketing FDA, diabetes, pharma
The US Food and Drug Administration (FDA) has approved the Eversense Continuous Glucose Monitoring (CGM) system for use in people …
AstraZeneca’s Imfinzi becomes India’s first available immunotherapy for lung cancer
June 22, 2018Medical Communications, Sales and Marketing AstraZeneca, Imfinzi, India, NSCLC, lung cancer, pharma
In a big step forward for India as AstraZeneca announces that its checkpoint inhibitor Imfinzi (durvalumab) has secured approval in …
Roche’s Ocrevus cleared for NHS use in relapsing-remitting MS
June 22, 2018Medical Communications, Sales and Marketing MS, NICE, UK, multiple sclerosis, pharma
Roche and multiple sclerosis (MS) patients across England and Wales are celebrating the news that healthcare watchdog NICE has recommended …
Elderly cancer cases to increase 80% by 2035, says CRUK
June 21, 2018Medical Communications, Research and Development CRUK, Cancer, Cancer Research UK, NHS, UK, pharma
A new report from Cancer Research UK has indicated that the number of UK citizens over the age of 75 …
Purdue culls 350 positions, eradicates sales force
June 21, 2018Medical Communications, Sales and Marketing Purdue Pharma, opioid crisis, opioids, pharma
Bowing to the pressure applied by external groups for the part it has played in the ongoing opioid crisis, Purdue …
Anika’s osteoarthritis pain drug falls short at Phase 3
June 21, 2018Research and Development Anika Therapeutics, Cingal, osteoarthritis, pharma
Anika Therapeutics has become the latest in a recent string of firms to suffer a failure in a late-stage trial, …
Novo’s oral semaglutide beats Victoza and Januvia in diabetes
June 21, 2018Research and Development Januvia, MSD, Novo Nordisk, Victoza, pharma, semaglutide
Novo Nordisk has released new data for its oral semaglutide diabetes therapy from two trials, showing that the GLP-1 analogue …
Aquinnah Pharmaceuticals receives $3.4 million grant to advance ALS therapies
June 21, 2018Research and Development, Sales and Marketing Aquinnah Pharmaceuticals, als, amyotrophic lateral sclerosis, pharma
Aquinnah Pharmaceuticals has announced that it has been awarded a $3.4 million grant from the National Institute of Neurological Disorders …
NHS could save £7 billion via new diagnostic techniques
June 20, 2018Medical Communications, Research and Development NHS, pharma
Research commissioned by Innovate UK and the British In Vitro Diagnostics Association (BIVDA) has revealed that the NHS could save …
Sarepta shares surge after gene therapy leads to microdystrophin expression in DMD patients
June 20, 2018Research and Development Duchenne Muscular Dystrophy, pharma, sarepta
This week, shares in Sarepta Therapeutics rocketed by 80% after the company released preliminary data from a Phase 1/2a trial …
Kallyope and Novo Nordisk announce obesity and diabetes collaboration
June 20, 2018Research and Development Kallyope, Novo Nordisk, diabetes, obesity, pharma
Kallyope and Novo Nordisk have entered into a research collaboration and option agreement to discover novel peptide therapeutics for the …
“Extremely promising” blood test for autism impresses with 88% accuracy
June 20, 2018Research and Development autism, pharma
A blood test designed to support the clinical determination of whether a child is on the autistic spectrum has been …
Facebook unveils new feature to battle opioid crisis
June 20, 2018Medical Communications, Research and Development, Sales and Marketing FDA, Facebook, US, opioid crisis, opioids, pharma
Despite its highly-publicised transgressions recently, tech giant Facebook is looking to do the right thing by wading into the ongoing …
FDA places hold on Ziopharm CAR-T trial
June 19, 2018Manufacturing and Production, Research and Development CAR-T, FDA, pharma, ziopharm
CAR-T is emerging as one of the most potentially exciting therapies in the industry, particularly as a beacon for the …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
